Contineum Therapeutics, Inc. Class A Common Stock (CTNM) ownership: Top institutional holder: SUVRETTA CAPITAL MANAGEMENT, LLC ($37.11M). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2841334.00 | $37.11M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 2734836.00 | $35.59M | 2026-03-31 |
| JOHNSON & JOHNSON | 1979173.00 | $25.85M | 2026-03-31 |
| FRANKLIN RESOURCES INC | 1839227.00 | $24.02M | 2026-03-31 |
| Balyasny Asset Management L.P. | 1685635.00 | $22.01M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1535449.00 | $20.05M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 1420838.00 | $18.56M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1296012.00 | $16.93M | 2026-03-31 |
Back to CTNM overview · CTNM earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.